XML 32 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value of Financial Instruments  
Schedule of fair value inputs

September 30, 2022

December 31, 2021

Current stock price

$

1.73

$

3.04

Estimated volatility of future stock price

85.00

%

133.13

%

Risk free interest rate

3.94

%

0.55

%

Contractual term

1.16

years

1.90

years

The following table presents quantitative information about the inputs and valuation methodologies used for the Company’s fair value measurements of contingent consideration classified as Level 3 as of September 30, 2022 and December 31, 2021:

As of September 30, 2022

Valuation 

Significant 

Weighted Average 

    

 Methodology

    

 Unobservable Input

    

 (range, if applicable)

Elusys Revenue earn-out

Discounted cash flow analysis

Timing of expected payments

2025-2036

Discount rate

24.5%

Future revenue projections

$

325.9 million

Elusys Contract deferred consideration

Discounted cash flow analysis

Timing of expected payments

2023

Discount rate

15%

Future revenue projections

$

7.6 million

As of September 30, 2021

Valuation 

Significant 

Weighted Average 

    

 Methodology

    

 Unobservable Input

    

 (range, if applicable)

Pelican contingent consideration

 

Probability weighted income approach

 

Milestone dates

 

2022-2031

 

 

Discount rate

 

7.52

 

  

 

Probability of occurrence

 

4.9% to 55%

Schedule of fair value of financial instruments measured on a recurring basis

The fair value of financial instruments measured on a recurring basis is as follows:

As of September 30, 2022

Description

    

Total

    

Level 1

    

Level 2

    

Level 3

Assets:

Short-term investments

$

43,789,736

$

43,789,736

 

 

Liabilities:

 

  

 

  

 

  

 

  

Contingent consideration

17,069,114

 

17,069,114

Warrant liability

274

 

 

274

As of December 31, 2021

Description

    

Total

    

Level 1

    

Level 2

    

Level 3

Assets:

Short-term investments

$

88,324,922

$

88,324,922

 

 

Liabilities:

 

  

 

  

 

  

 

  

Contingent consideration

3,342,515

 

3,342,515

Warrant liability

11,020

 

11,020

Schedule of change in fair value, as determined by Level 3 inputs, for all assets and liabilities using unobservable Level 3 inputs

The following tables summarize the change in fair value, as determined by Level 3 inputs, for all Pelican assets and liabilities using unobservable Level 3 inputs for the nine months ended September 30, 2022 and 2021:

Pelican

Elusys

Total

Contingent

Contingent

Contingent

Warrant

    

Consideration

 

Consideration

 

Consideration

 

Liability

Balance at December 31, 2021

$

3,342,515

$

$

3,342,515

$

11,020

Change in fair value

 

(3,342,515)

(3,342,515)

(10,746)

Acquisition of Elusys

39,853,685

39,853,685

Payment of receivable consideration

(20,784,571)

(20,784,571)

Payment of deferred cash consideration

(2,000,000)

(2,000,000)

Balance at September 30, 2022

$

$

17,069,114

$

17,069,114

$

274

Pelican

 

Contingent 

Warrant

Consideration

 

Liability

Balance at December 31, 2020

$

2,912,515

$

33,779

Change in fair value

406,000

(2,808)

Balance at September 30, 2021

$

3,318,515

$

30,971